Company Filing History:
1 out of 45 
1 out of 178 
Years Active: 2019
Title: The Innovative Contributions of Benjamin Haenselmann
Introduction
Benjamin Haenselmann is a notable inventor based in Freiburg im Breisgau, Germany. He has made significant strides in the field of cancer diagnostics, particularly through his innovative work involving exosomes. His contributions are vital in advancing medical technology and improving patient outcomes.
Latest Patents
Haenselmann holds a patent for a process aimed at the diagnosis of cancer by utilizing exosomes. This invention relates to an in vitro process for diagnosing prostate cancer and other tumor types using exosomes obtained from body fluids. His work in this area represents a significant advancement in cancer detection methodologies.
Career Highlights
Throughout his career, Benjamin Haenselmann has been associated with prestigious institutions such as Albert-Ludwigs-Universität Freiburg and the Karlsruhe Institute of Technology. His work at these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Haenselmann has worked alongside notable colleagues, including Irina Nazarenko and Andrew Cato. These collaborations have further enriched his research and have played a crucial role in the development of his innovative diagnostic processes.
Conclusion
Benjamin Haenselmann's contributions to cancer diagnostics through his patented processes highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in cancer detection and treatment.